Income tax expense · 2011–2025
Sinovac Biotech income tax expense
−$63.3M−$65.4M · FY2025
Sinovac Biotech (SVA) reported −$63.3M in income tax expense for fiscal 2025, −$65.4M from the year before.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$63.3M | −$65.4M | Open → |
| FY20242024-12-31 | $2.2M | −94.0% | Open → |
| FY20232023-12-31 | $36.4M | +216.7% | Open → |
| FY20222022-12-31 | $11.5M | −99.7% | Open → |
| FY20212021-12-31 | $3.4B | +10,867.4% | Open → |
| FY20202020-12-31 | $31.4M | +460.9% | Open → |
| FY20192019-12-31 | $5.6M | −46.5% | Open → |
| FY20182018-12-31 | $10.5M | +25.6% | Open → |
| FY20172017-12-31 | $8.3M | +213.0% | Open → |
| FY20162016-12-31 | $2.7M | −10.8% | Open → |
| FY20152015-12-31 | $3.0M | +44.3% | Open → |
| FY20142014-12-31 | $2.1M | +$4.3M | Open → |
| FY20132013-12-31 | −$2.2M | −$1.3M | Open → |
| FY20122012-12-31 | −$884,000 | −$6.0M | Open → |
| FY20112011-12-31 | $5.1M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech income tax expense |url=https://companiesranked.com/en/company/sinovac-biotech/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech income tax expense. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/income-tax-expenseBibTeX
@misc{companiesranked-en-company-sinovac-biotech-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech income tax expense — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.